Exclusive

Publication

Byline

Clinical Trial: Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07513480) titled 'Pretreatment With CPA-EE, Metformin and Myoinositol in PCOS With High AMH' on March 02. Br... Read More


Clinical Trial: Virtual Reality-Based Simulation Training for Antegrade Anterior Column Acetabular Screw Placement in Orthopedic Residents

U.S., April 8 -- ClinicalTrials.gov registry received information related to the study (NCT07515092) titled 'Virtual Reality-Based Simulation Training for Antegrade Anterior Column Acetabular Screw Pl... Read More


फिर ठप हुआ स्ट्रेट ऑफ होर्मुज, लेबनान पर इजरायली हमले के बाद ईरान का ऐक्शन

नई दिल्ली, अप्रैल 8 -- Strait of Hormuz closed again: पश्चिम एशिया की जंग एक बार फिर से भड़कती हुई नजर आ रही है। सीजफायर के ऐलान के 24 घंटे के भीतर ईरान ने एक बार फिर से होर्मुज स्ट्रेट को बंद करने का... Read More


सेक्टर-62 में मेट्रो के काम के कारण दो महीने सर्विस रोड बाधित रहेगी

नोएडा, अप्रैल 8 -- नोएडा, विक्रम शर्मा। सेक्टर-62 के पास से गाजियाबाद की ओर जाने वाली सर्विस रोड पर दो महीने तक यातायात बाधित रहेगा। नौ अप्रैल से दस जून तक यह व्यवस्था रहेगी। यहां पर मेट्रो लाइन से सं... Read More


Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More


Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability ... Read More


Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab... Read More


Singapore Clinical Trial: A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of Firmonertinib Compared with Investigator’s Choice of Osimertinib or Afatinib as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic Non-Small-Cell Lung Cancer with Epidermal Growth Factor Receptor P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations (ALPACCA)

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Global, Phase 3, Randomized, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety o... Read More


Singapore Clinical Trial: A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of MK-2214 in Participants with Early Alzheimer's Disease

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study to Evaluate the Effic... Read More


Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, April 8 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascend... Read More